-+ 0.00%
-+ 0.00%
-+ 0.00%

Hemab Therapeutics Hldgs Q3 EPS $(0.58) Misses $(0.52) Estimate

Benzinga·11/10/2026 12:06:28
Listen to the news
Hemab Therapeutics Hldgs (NASDAQ:COAG) reported quarterly losses of $(0.58) per share which missed the analyst consensus estimate of $(0.52) by 11.54 percent.